ViGeneron to develop next-gen eye gene therapies after fundi...

Germany’s ViGeneron is to advance development of its next-generation ophthalmology gene therapy pipeline after a series A financing round.

Mereo’s brittle bone drug likely to shrug off phase 2b fail,...

AZ and Novoheart collaborate on 'heart in a jar', to develop...

Stem cell biotech Novoheart is to collaborate with AstraZeneca to develop a “heart in a jar” that will be used to help develop new heart failure drugs.

Another NASH setback as CymaBay drops seladelpar

BMS' Opdivo/Yervoy combo hits a snag in adjuvant melanoma

Allergan builds case for migraine drug ubrogepant as FDA ver...